B Gazzard
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 15
- HIV Research and Treatment 15
-
- HIV/AIDS drug development and treatment 15
- HIV/AIDS Research and Interventions 13
- Tuberculosis Research and Epidemiology 5
- Co-authors
- Mark NelsonDavid HawkinsMark BowerO. A. N. HusainGraeme MoyleKate FifePaul FoxJ N Harcourt-Webster
- Journals
- AIDS (7 papers)HIV Medicine (5 papers)Journal of Clinical Pathology (3 papers)Clinical Infectious Diseases (2 papers)International Journal of STD & AIDS (2 papers)
- Partner nations
- United KingdomIndiaUnited States
In The Last Decade
B Gazzard
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 109
- Virology 319
- Infectious Diseases 647
- Emergency Medicine 220
- Microbiology 93
- Epidemiology 477
Countries citing papers authored by B Gazzard
This map shows the geographic impact of B Gazzard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Gazzard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Gazzard more than expected).
Fields of papers citing papers by B Gazzard
This network shows the impact of papers produced by B Gazzard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Gazzard. The network helps show where B Gazzard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B Gazzard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A comparative analysis of risk factors associated with efavirenz, darunavir/ritonavir, lopinavir/ritonavir, atazanavir/ritonavir and renal impairment | 2011 | 3 |
| 2 | 2008 | 37 | |
| 3 | 2002 | 6 | |
| 4 | 2001 | 31 | |
| 5 | 2001 | 100 | |
| 6 | 2001 | 24 | |
| 7 | 1999 | 131 | |
| 8 | 1999 | 61 | |
| 9 | 1996 | 14 | |
| 10 | 1996 | 87 | |
| 11 | 1996 | 30 | |
| 12 | 1995 | 38 | |
| 13 | 1992 | 65 | |
| 14 | Model of care for the hospital treatment of individuals with HIV infection. | 1991 | 5 |
| 15 | 1990 | 1 | |
| 16 | 1990 | 19 | |
| 17 | 1989 | 67 | |
| 18 | 1989 | 72 | |
| 19 | 1989 | 11 | |
| 20 | 1983 | 17 |
About B Gazzard
B Gazzard is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Hepatology and Epidemiology, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (15 papers), Pneumocystis jirovecii pneumonia detection and treatment (14 papers), HIV/AIDS Research and Interventions (13 papers), HIV-related health complications and treatments (8 papers), Viral-associated cancers and disorders (7 papers), Tuberculosis Research and Epidemiology (5 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Virology (319 citations), Infectious Diseases (647 citations), Emergency Medicine (220 citations), Microbiology (93 citations) and Epidemiology (477 citations). B Gazzard has collaborated with scholars based in United Kingdom, India and United States. Frequent co-authors include Mark Nelson, David Hawkins, Mark Bower, O. A. N. Husain, Graeme Moyle, Kate Fife, Paul Fox, J N Harcourt-Webster, G M Connolly and D.C. Shanson. Their work appears in journals such as AIDS, HIV Medicine, Journal of Clinical Pathology, Clinical Infectious Diseases and International Journal of STD & AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.